FUCILE, SERENA
 Distribuzione geografica
Continente #
EU - Europa 483
NA - Nord America 446
AS - Asia 164
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.097
Nazione #
US - Stati Uniti d'America 424
GB - Regno Unito 274
IT - Italia 91
CN - Cina 81
SE - Svezia 36
SG - Singapore 26
IN - India 25
CA - Canada 21
DE - Germania 17
KR - Corea 16
FI - Finlandia 15
IE - Irlanda 11
TR - Turchia 10
BE - Belgio 9
RU - Federazione Russa 8
FR - Francia 6
NL - Olanda 5
UA - Ucraina 3
CO - Colombia 2
DK - Danimarca 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
PT - Portogallo 1
RO - Romania 1
Totale 1.098
Città #
Southend 261
Chandler 80
Milan 58
Seattle 39
Ann Arbor 27
Wilmington 26
Princeton 25
Dearborn 22
New York 18
Beijing 17
Boise 15
Toronto 14
Fairfield 13
Houston 13
Singapore 13
Des Moines 11
Dublin 11
Phoenix 11
Ashburn 10
Bengaluru 10
Boardman 10
Shenyang 10
Brussels 9
Mountain View 9
Woodbridge 9
Nanjing 8
Ottawa 7
Redmond 6
Seoul 6
Cambridge 5
Falls Church 5
Helsinki 5
Jinan 5
Berlin 4
Hebei 4
Nanchang 4
Shanghai 4
Andover 3
Atlanta 3
Frankfurt am Main 3
Haikou 3
Mumbai 3
Redwood City 3
Sakarya 3
San Diego 3
Serra 3
Zhengzhou 3
Bitonto 2
Bogotá 2
Changsha 2
Exton 2
Fremont 2
Jiaxing 2
New Haven 2
Pskov 2
Rubiera 2
Saint Petersburg 2
Taiyuan 2
Zoagli 2
Albany 1
Ankara 1
Bedford 1
Chengdu 1
Chisinau 1
Chiswick 1
Hangzhou 1
Hefei 1
Indianapolis 1
Jakarta 1
Kuala Lumpur 1
Las Vegas 1
Lausanne 1
Lawrence 1
Leeds 1
Leiden 1
Lisbon 1
London 1
Modesto 1
Munich 1
Ningbo 1
Norwalk 1
Odense 1
Oklahoma City 1
Orofino 1
Pisa 1
Quanzhou 1
Rome 1
Silver Spring 1
Støvring 1
Surat 1
Tallinn 1
Tianjin 1
Tokyo 1
Toledo 1
Veracruz 1
Totale 894
Nome #
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 168
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients 130
Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients 128
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients : an observational study in real-life settings 119
Limited Sampling Strategies for the Estimation of Raltegravir Daily Exposure in HIV-Infected Patients 114
Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections 101
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 96
Is it time to revise antiretrovirals dosing? : a pharmacokinetic viewpoint 88
Comparison of the ARK Immunoassay With High-Performance Liquid Chromatography With Ultraviolet Detection for Therapeutic Drug Monitoring of Linezolid 85
Comparison of the QMS® analyzer with HPLC-UV for the quantification of lamotrigine concentrations in human plasma samples 74
Lights and shadows of the actual European guidelines on bioanalytical method validation : the case of raltegravir 73
Totale 1.176
Categoria #
all - tutte 3.137
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.137


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 16 3 3 6 4 28 15 11 9 26 6 7
2020/202193 17 0 2 0 10 6 2 12 15 4 21 4
2021/2022122 11 1 0 2 13 4 9 5 30 13 7 27
2022/2023195 28 35 18 22 14 36 0 8 27 4 3 0
2023/202499 0 10 10 8 30 13 0 5 0 1 10 12
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.176